7 Responses

  1. The Sarcastic Medved Type 2
    The Sarcastic Medved Type 2 January 21, 2013 at 5:34 am | | Reply

    It will never happen. Companies that manufacture meters and such are stuck in the mid 20th century.

  2. John
    John January 21, 2013 at 9:19 am | | Reply

    The medical device industry could learn a lot from the EU… There’s still profit in interoperability, it just encourages you to make better products..

    One software package, one cable (or wireless),
    Any Meter
    Any Pump
    Any CGMS or Smart Device..

    It works for cellphones and the EU standardizing the charge connector (OneChargerForAll) … it can work for diabetes hardware and software..

    http://ec.europa.eu/enterprise/sectors/rtte/chargers/index_en.htm

    Consider Glooko Inc’s product as one of the leaders in forcing interoperability along with Dexcom being associated with so many device vendors now…

    Also I want to give mention to Continua, although it seems the diabetes industry is mostly ignoring them (Though it seems Accuchek actually participates with them, Smartpix has some connection to Continua compliance) since tying users to only their products is extremely profitable when there may be better solutions..

  3. Iris
    Iris January 21, 2013 at 6:55 pm | | Reply

    Major thankies for the article.Thanks Again. Much obliged.

  4. Type1Engineer
    Type1Engineer January 22, 2013 at 12:44 am | | Reply

    Great article, Mike and Amy.

    Continua seems like an interoperability/connectivity agreement between companies that choose to adopt their standards.

    IEEE 11073 is both a healthcare connectivity standard and a data storage standard (recognized worldwide-very well reputed with scientists/engineers/technologists).

    (In my opinion) In order to be successful with medical device integration (essentially a “diabetes operating system” (and a device that is dedicated to doing such), additionally with access to data remotely, via the cloud. ):

    1. Adopt a data standard for storing all structures of data (e.g. any data generated by the medical devices used).

    2. Decide on which forms of wireless communication (a wide array of forms-including NFC and RFID) are acceptable for certain medical devices, while giving the user freedom. (i.e. a child with a CGM might need to have all data generated by the CGM uploaded continuously to “the cloud” via cellular/mobile data services. I asked a EE-whose child is Type 1-if the same antenna used for Bluetooth can be used for cellular/mobile data communication and he essentially said yes. So bulk would be less of a concern, given if the battery was decent, since more power is consumed. A CGM transmitter (at least) theoretically is capable of sending data to mobile/cellular towers, too.) Note that all of the mobile/cellular communications are encrypted, digitally. I am unsure of what standard it is encrypted to, though. If data is sent mobile, it needs to be using the worldwide standard, GSM, on the standard bands used worldwide. Providers that use CDMA (proprietary band used in North America with certain providers–such as Verizon and Sprint) are unsuitable and are out of the question. There is a medical device company that sends all of its data wirelessly from its patients’ pacemakers and defibrillators via GSM. The company is called Biotronik. A description of the device can be seen here. http://www.biotronik.com/wps/wcm/connect/en_us_web/biotronik/sub_top/patients/dianostics_and_therapies/home_montitoring

    3. Figure out what level of encryption is needed (i.e. for all types of wireless communication and “cloud” access). The FDA already has protocols and “standards” for encryption. With CGM transmitters, for example, the companies use RF (analog) technology with encryption.

    Anyways, all forms of health related data need to be stored in a standard way, at least in the US, if not globally (and also be given to the government). That is the most effective way to determine outcomes. For example, there is a Swedish study, where all Type 1s in a certain time period within the country are tracked, determining their overall risk for kidney disease. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889782/

    Also, certain companies (like Medtronic), require users to upload their pump and CGM data online on to their servers, via the Internet. They do use patients’ data for their own personal analysis. If any medical device company is allowed to take data stored on one of their devices via the Internet, they should be obligated by law to give it all to the government.

    Another problem that could be solved with this data and interoperability standard emerging is accessibility to the blind. If we have some sort of “diabetes operating system” with a dedicated device (due to–proper and universal–connectivity and data storage standards) we could give dedicated access through a “control device” regardless of whether the device was previously “completely accessible” or not.

    Anyways, I just started school after being gone for a year and I am trying to hang on, dealing with a challenging autoimmune disease. I wish I could write and communicate more with all of you, but I have to get back to my homework.

  5. Juerg
    Juerg March 5, 2013 at 2:20 am | | Reply

    If there where no patents…

Leave a Reply